Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China

被引:21
作者
Wang, Yafei [1 ]
Zhou, Ying [1 ]
Yang, Zhen [1 ]
Xia, Dongping [1 ]
Hu, Yi [1 ]
Geng, Shuang [1 ]
机构
[1] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Respirat, Shengli St 26, Wuhan 430014, Hubei, Peoples R China
关键词
Lymphocyte; D-Dimer; SARS-CoV-2; Severe pneumonia; CORONAVIRUS; PROTECTS; SARS;
D O I
10.1159/000507940
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background:A new virus broke out in Wuhan, Hubei, China, that was later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical characteristics of severe pneumonia caused by SARS-CoV-2 are still not clear.Objectives:The aim of this study was to explore the clinical characteristics and risk factors of severe pneumonia caused by the SARS-CoV-2 in Wuhan, China.Methods:The study included patients hospitalized at the Central Hospital of Wuhan who were diagnosed with COVID-19. Clinical features, chronic comorbidities, demographic data, laboratory examinations, and chest computed tomography (CT) scans were reviewed through electronic medical records. SPSS was used for data analysis to explore the clinical characteristics and risk factors of patients with severe pneumonia caused by SARS-CoV-2.Results:A total of 110 patients diagnosed with COVID-19 were included in the study, including 38 with severe pneumonia and 72 with nonsevere pneumonia. Statistical analysis showed that advanced age, increased D-Dimer, and decreased lymphocytes were characteristics of the patients with severe pneumonia. Moreover, in the early stage of the disease, chest CT scans of patients with severe pneumonia showed that the illness can progress rapidly.Conclusions:Advanced age, decreased lymphocytes, and D-Dimer elevation are important characteristics of patients with severe COVID-19. Clinicians should focus on these characteristics to identify high-risk patients at an early stage.
引用
收藏
页码:649 / 657
页数:9
相关论文
共 25 条
  • [1] Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
    不详
    [J]. PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2020, 16 (01): : 9 - 26
  • [2] [Anonymous], 2020, NATURE 0203, DOI DOI 10.1101/2020.01.22.914952
  • [3] Castro DJ, 2001, RESPIRATION, V68, P371
  • [4] Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
    Chan, Jasper Fuk-Woo
    Kok, Kin-Hang
    Zhu, Zheng
    Chu, Hin
    To, Kelvin Kai-Wang
    Yuan, Shuofeng
    Yuen, Kwok-Yung
    [J]. EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 221 - 236
  • [5] Identification of a novel coronavirus in patients with severe acute respiratory syndrome
    Drosten, C
    Günther, S
    Preiser, W
    van der Werf, S
    Brodt, HR
    Becker, S
    Rabenau, H
    Panning, M
    Kolesnikova, L
    Fouchier, RAM
    Berger, A
    Burguière, AM
    Cinatl, J
    Eickmann, M
    Escriou, N
    Grywna, K
    Kramme, S
    Manuguerra, JC
    Müller, S
    Rickerts, V
    Stürmer, M
    Vieth, S
    Klenk, HD
    Osterhaus, ADME
    Schmitz, H
    Doerr, HW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) : 1967 - 1976
  • [6] Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation
    Frantzeskaki, Frantzeska
    Armaganidis, Apostolos
    Orfanos, Stylianos E.
    [J]. RESPIRATION, 2017, 93 (03) : 212 - 225
  • [7] Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
    Hamming, I
    Timens, W
    Bulthuis, MLC
    Lely, AT
    Navis, GJ
    van Goor, H
    [J]. JOURNAL OF PATHOLOGY, 2004, 203 (02) : 631 - 637
  • [8] Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, 10.1016/S0140-6736(20)30211-7]
  • [9] Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients
    Huang, Fengming
    Guo, Jing
    Zou, Zhen
    Liu, Jun
    Cao, Bin
    Zhang, Shuyang
    Li, Hui
    Wang, Wei
    Sheng, Miaomiao
    Liu, Song
    Pan, Jingcao
    Bao, Changjun
    Zeng, Mei
    Xiao, Haixia
    Qian, Guirong
    Hu, Xinjun
    Chen, Yuanting
    Chen, Yu
    Zhao, Yan
    Liu, Qiang
    Zhou, Huandi
    Zhu, Jindong
    Gao, Hainv
    Yang, Shigui
    Liu, Xiaoli
    Zheng, Shufa
    Yang, Jiezuan
    Diao, Hongyan
    Cao, Hongcui
    Wu, Ying
    Zhao, Min
    Tan, Shuguang
    Guo, Dan
    Zhao, Xiliang
    Ye, Yicong
    Wu, Wei
    Xu, Yingchun
    Penninger, Josef M.
    Li, Dangsheng
    Gao, George F.
    Jiang, Chengyu
    Li, Lanjuan
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [10] The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China
    Hui, David S.
    Azhar, Esam I.
    Madani, Tariq A.
    Ntoumi, Francine
    Kock, Richard
    Dar, Osman
    Ippolito, Giuseppe
    Mchugh, Timothy D.
    Memish, Ziad A.
    Drosten, Christian
    Zumla, Alimuddin
    Petersen, Eskild
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 91 : 264 - 266